(Press-News.org) (WASHINGTON, June 21, 2024) – Patients with chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphomas (NHLs) who received frequent tests for immunoglobulin G (IgG) were less likely to experience severe infections compared with those who didn’t, according to a study published in Blood Advances. Moreover, only half of patients undergo such testing.
Patients with blood cancers such as CLL and NHL are at elevated risk for potentially life-threatening infections due to low blood levels of immunoglobulins — proteins that help the immune system fight off infections. As many as one-half of patients with CLL and a third of those with NHL die from infection complications.
Studies have shown that immunoglobulin replacement therapy (IgRT) reduces both recurrent and severe infections, potentially saving patients’ lives. In the present study, those who received IgRT had fewer infections, required fewer antimicrobial medications, and had higher blood levels of IgG, the most common type of immunoglobulin, following the administration of IgRT.
“This is the first large, real-world study to examine current practices in IgG testing and the use of IgRT among patients with CLL and NHL,” said Jacob D. Soumerai, MD, assistant professor of medicine at Massachusetts General Hospital Cancer Center and Harvard Medical School and the study’s lead investigator. “Our most striking finding is that real-world practice is highly variable. We found that many patients are not tested for IgG deficiency, and IgRT is often not given despite the development of recurrent infections.” Moreover, frequent IgG testing is associated with a reduction in subsequent development of severe infections, he added.
For the study, Dr. Soumerai and his colleagues analyzed medical records of 17,192 adult patients treated for CLL (3,920) or NHL (13,232) at one of eight affiliated hospitals in the Boston area between 2010 and 2023. Median patient follow-up in the database was four and a half years. The patients’ de-identified data was obtained from the Mass General Brigham Research Patient Data Registry. The average patient age was 66; 58% were male and 90% were white. Among patients with NHL, 51.2% underwent IgG testing and 4.7% received IgRT; among those with CLL, 67% received IgG testing and 6.5% were treated with IgRT.
Among patients who received at least one IgG test, the researchers compared blood levels of IgG, the proportion of patients with IgG levels below 500 mg/dL (deemed low), the rate of infections, and the use of antimicrobial medications at three, six, and 12 months before and after the first time each patient received IgRT. The results were similar across patient subgroups (e.g., males vs. females), blood cancer type, and type of treatment received.
Dr. Soumerai and his colleagues also found that increased IgG testing is associated with a significantly lower risk of subsequently developing severe infection. After adjusting for potential confounders, patients with CLL and NHL who had three or more preceding IgG tests had 92% and 86% lower odds of later developing a severe infection, respectively.
“Within each disease cohort, patients with three or more IgG tests were more likely to have low IgG detected and also more likely to receive IgRT,” said Dr. Soumerai. “These findings suggest that patients known to have low levels of IgG might be more likely to communicate recurrent minor infections to their hematologists, leading to improved IgRT use.”
Although clinical guidelines from various professional medical societies generally recommend IgG testing, specific recommendations regarding when and how often patients should be tested vary widely and, as the study revealed, IgG testing practices vary among hematologists caring for patients with CLL and NHL. In both patient cohorts, the number of IgG tests per patient spanned a wide range, with many patients not receiving any IgG testing during the study period. “This underlines the urgent need to establish clear consensus on best practices for IgG testing and IgRT use in patients with CLL and NHL, to reduce recurrent infections in our patients,” Dr. Soumerai said.
This study is limited in that it is retrospective and only included patients treated in the Mass General Brigham health care system; it did not capture patients who may have received IgRT outside of this network. Furthermore, most of the patients in the registry were white and thus not fully representative of the U.S. population.
The study was funded by Takeda Pharmaceuticals USA, Inc. Several study authors are employed by Takeda or by companies providing paid consulting services to Takeda.
###
Blood Advances (bloodadvances.org) is an online, open access journal publishing more peer-reviewed hematology research than any other academic journal worldwide. Blood Advances is part of the Blood journals portfolio (bloodjournals.org) from the American Society of Hematology (ASH) (hematology.org).
END
Earth and environmental scientists reported that as human socio-economic activities increase, greenhouse gas emissions will rise, leading to more frequent extreme weather events such as droughts and floods. However, a research team from Pohang University of Science and Technology (POSTECH) has published a study suggesting that anthropogenic greenhouse gases might actually mitigate droughts, offering a new perspective on the impact of human activities on nature.
Professor Jonghun Kam from the Division of Environmental Science and Engineering at POSTECH ...
Co-authored by Pascal François (HEC Montreal) and Georges Hubner (University of Liège), both professors of finance, The Complete Guide to Portfolio Performance: Appraise, Analyse, Act, just published by Wiley, is a comprehensive guide to all aspects of financial portfolio performance. The book explores the essential topics of portfolio performance measurement in a realistic and rigorous way, with usable content clearly illustrated by practical examples that demonstrate the application of the concepts discussed.
Portfolio management is a complex field, requiring in-depth expertise ...
As a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including pain, loss of speech, extreme agitation, and distress, gastrointestinal symptoms, and profound sleep disturbance. With no approved treatment, clinical specialists have had few options to help alleviate this suffering until now. A groundbreaking clinical trial collaboration between study lead and principal investigator Lynda Polgreen, MD, MS, Investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA (TLI) and Associate ...
Many drug and antibody discovery pathways focus on intricately folded cell membrane proteins: when molecules of a drug candidate bind to these proteins, like a key going into a lock, they trigger chemical cascades that alter cellular behavior. But because these proteins are embedded in the lipid-containing outer layer of cells, they are tricky to access and insoluble in water-based solutions (hydrophobic), making them difficult to study.
"We wanted to get these proteins out of the cell membrane, so we redesigned them as hyperstable, soluble analogues, which look like membrane proteins but are much ...
In a world striving for sustainability, understanding the hidden half of a living plant – the roots – is crucial. Roots are not just an anchor; they are a dynamic interface between the plant and soil, critical for water uptake, nutrient absorption, and, ultimately, the survival of the plant. In an investigation to boost agricultural yields and develop crops resilient to climate change, scientists from Lawrence Berkeley National Laboratory’s (Berkeley Lab’s) Applied Mathematics and Computational Research (AMCR) and Environmental Genomics and Systems Biology (EGSB) Divisions have made a significant leap. Their latest innovation, RhizoNet, harnesses the power ...
Press release under embargo:
Cleveland Clinic Study Shows Weight Loss Surgery Cuts Risk of Heart Complications and Death in Patients with Obstructive Sleep Apnea and Obesity
First-of-its-kind MOSAIC study shows weight-loss surgery is associated with a 42% reduction in risk of heart complications and 37% reduction in risk of death in patients with obstructive sleep apnea
Under embargo until Friday, June 21, 2024, 9:00 AM ET, CLEVELAND: A Cleveland Clinic study shows that bariatric surgery performed in patients with obesity and moderate to severe obstructive sleep apnea is associated with a significantly lower risk of ...
Artificial intelligence continues to squirm its way into many aspects of our lives. But what about biology, the study of life itself? AI can sift through hundreds of thousands of genome data points to identify potential new therapeutic targets. While these genomic insights may appear helpful, scientists aren’t sure how today’s AI models come to their conclusions in the first place. Now, a new system named SQUID arrives on the scene armed to pry open AI’s black box of murky internal logic.
SQUID, ...
A new UCLA Health study has found that resilient people exhibit neural activity in the brain regions associated with improved cognition and regulating of emotions, and were more mindful and better at describing their feelings. The same group also exhibited gut microbiome activity linked to a healthy gut, with reduced inflammation and gut barrier.
For the study, rather than examine microbiome activity and composition linked to disease conditions-- like anxiety and depression -- the researchers wanted to flip the script and study the gut microbiome and brain in healthy, resilient people who effectively cope with different types of stress, including discrimination ...
Nightshade plants produce a diverse array of compounds with therapeutic potential. Researchers at CeMM have now identified an artificial variant inspired by the Withanolides group that acts highly specifically against leukemia cells. Using state-of-the-art chemical and genetic high-throughput analyses, the team led by Georg Winter not only confirmed its effectiveness but also elucidated its mechanism of action: the molecule disrupts the cholesterol metabolism of tumor cells. The study's findings ...
Green hydrogen often, but certainly not always, leads to CO2 gains. This claim is based on research published in Nature Energy by Kiane de Kleijne from Radboud University and Eindhoven University of Technology. “If you calculate the entire life cycle of green hydrogen production and transport, CO2 gains may be disappointing. However, if green hydrogen is produced from very clean electricity and locally, it can really help reduce emissions.”
It is thought that green hydrogen can make ...
